Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 14.96 billion as of December 5, 2025. Its market cap has increased by 46.38% in one year.

Market Cap

14.96B

Enterprise Value

15.12B

Revenue

224.83M

Ranking

n/a

PE Ratio

n/a

Stock Price

56.50

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 14.96B, a decrease of -10.78%. That is a compound annual growth rate of -1.10%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	14.96B	39.87%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	258.22B
PharmaEssentia	191.95B
Lotus Pharmaceutical	78.89B
Bora Pharmaceuticals Co., LTD.	65.31B
Lin BioScience	33.46B
Oneness Biotech	32.96B
Lumosa Therapeutics	32.77B
Center Laboratories	27.88B

Market Cap Rankings